Related Experiment Video
Updated: May 6, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Structural and Serological Characterization of Yet Another New O Antigen, O86, in Proteus mirabilis Clinical Strains
Dominika Drzewiecka1, Evgeniya A Levina2,3, Alexander S Shashkov2
1Department of Biology of Bacteria, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.
Abstract:
Bacteria from the genus Proteus are facultative human pathogens, primarily attacking the urinary tract and wounds. A total of 85 O serogroups have been identified so far among these bacilli. P. mirabilis Bprz 86 was isolated from the fistula of a patient in Łódź, Poland. Enzyme-Linked Immunosorbent Assay (ELISA) and Western blotting studies involving the P. mirabilis Bprz 86 lipopolysaccharide (LPS) and the strain-specific rabbit antiserum indicated that the strain, which does not belong to any of the O1-O85 serogroups, shares a common epitope with Proteus O17 antigens and is identical to another clinical P. mirabilis strain, Sm 120, isolated from the urine of a patient in the area. The O-specific polysaccharide (O antigen) was obtained from P. mirabilis Bprz 86 LPS through mild acid degradation, and the six-constituent structure of its repeating unit was determined using chemical analyses and 1D and 2D 1H and 13C Nuclear Magnetic Resonance (NMR) spectroscopy. It includes (R)-3-hydroxybutanoyl, which, along with fucosamine and glucose residues, forms a fragment also present in the O17 antigens. Based on the obtained serological and chemical data, the two studied P. mirabilis isolates were proposed as candidates for a new successive O serogroup in the genus Proteus, O86.
Insights
A new Proteus O serogroup, O86, is proposed based on studies of P. mirabilis Bprz 86. This strain shares an epitope with Proteus O17 antigens and has a unique O-specific polysaccharide structure.
Area of Science:
- Microbiology
- Immunology
- Structural Chemistry
Background:
- Bacteria of the genus Proteus are significant human pathogens, particularly affecting the urinary tract and wounds.
- Eighty-five O serogroups have been identified within the Proteus genus.
- Proteus mirabilis Bprz 86, isolated from a patient fistula, did not fit existing serogroups.
Purpose of the Study:
- To characterize the lipopolysaccharide (LPS) and O-specific polysaccharide (O antigen) of Proteus mirabilis Bprz 86.
- To determine the serological relationship between P. mirabilis Bprz 86 and other Proteus strains.
- To propose a new O serogroup for Proteus based on structural and serological data.
Main Methods:
- Enzyme-Linked Immunosorbent Assay (ELISA) and Western blotting were used for serological analysis.
- Mild acid degradation of LPS was performed to isolate the O-specific polysaccharide.
- Nuclear Magnetic Resonance (NMR) spectroscopy (1D and 2D 1H and 13C) was employed for structural elucidation.
Main Results:
- P. mirabilis Bprz 86 shares a common epitope with Proteus O17 antigens.
- The O-specific polysaccharide of P. mirabilis Bprz 86 contains a unique six-constituent repeating unit.
- This repeating unit includes (R)-3-hydroxybutanoyl, fucosamine, and glucose residues, forming a fragment also found in O17 antigens.
- P. mirabilis Bprz 86 was found to be identical to another clinical isolate, P. mirabilis Sm 120.
Conclusions:
- The serological and chemical data support the characterization of P. mirabilis Bprz 86.
- The two studied P. mirabilis isolates (Bprz 86 and Sm 120) are proposed as candidates for a new Proteus O serogroup, O86.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022